Business Description
Oncolys BioPharma Inc
ISIN : JP3202170001
Description
Oncolys BioPharma Inc develops pharmaceutical products. The company is engaged in research and development of oncolytic viruses, drugs for serious infectious diseases, molecular targeted anti-cancer drugs, and tumor diagnostic agents.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.06 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 9.69 | |||||
| Beneish M-Score | -1.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -45.5 | |||||
| 3-Year EBITDA Growth Rate | 9.2 | |||||
| 3-Year EPS without NRI Growth Rate | 5.5 | |||||
| 3-Year FCF Growth Rate | 9.6 | |||||
| 3-Year Book Growth Rate | -18.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.54 | |||||
| 9-Day RSI | 34.42 | |||||
| 14-Day RSI | 36.49 | |||||
| 6-1 Month Momentum % | 23.47 | |||||
| 12-1 Month Momentum % | 32.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.03 | |||||
| Quick Ratio | 7.01 | |||||
| Cash Ratio | 4.44 | |||||
| Days Sales Outstanding | 374.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.3 | |||||
| Shareholder Yield % | 0.67 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -5806.68 | |||||
| Net Margin % | -5813.83 | |||||
| FCF Margin % | -4278 | |||||
| ROE % | -125.81 | |||||
| ROA % | -93.93 | |||||
| ROIC % | -365.9 | |||||
| ROC (Joel Greenblatt) % | -584.48 | |||||
| ROCE % | -110.67 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 335.78 | |||||
| PB Ratio | 7.44 | |||||
| Price-to-Tangible-Book | 7.86 | |||||
| EV-to-EBIT | -6.24 | |||||
| EV-to-EBITDA | -6.24 | |||||
| EV-to-Revenue | 361.12 | |||||
| EV-to-FCF | -8.14 | |||||
| Price-to-Median-PS-Value | 8.5 | |||||
| Price-to-Net-Current-Asset-Value | 8.56 | |||||
| Price-to-Net-Cash | 17.18 | |||||
| Earnings Yield (Greenblatt) % | -16.04 | |||||
| FCF Yield % | -11.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oncolys BioPharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 31.384 | ||
| EPS (TTM) (円) | -95.72 | ||
| Beta | 0.72 | ||
| Volatility % | 47.87 | ||
| 14-Day RSI | 36.49 | ||
| 14-Day ATR (円) | 35.564856 | ||
| 20-Day SMA (円) | 609.65 | ||
| 12-1 Month Momentum % | 32.3 | ||
| 52-Week Range (円) | 420 - 918 | ||
| Shares Outstanding (Mil) | 22.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oncolys BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oncolys BioPharma Inc Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Oncolys BioPharma Inc Frequently Asked Questions
What is Oncolys BioPharma Inc(TSE:4588)'s stock price today?
The current price of TSE:4588 is 円534.00. The 52 week high of TSE:4588 is 円918.00 and 52 week low is 円420.00.
When is next earnings date of Oncolys BioPharma Inc(TSE:4588)?
The next earnings date of Oncolys BioPharma Inc(TSE:4588) is .
Does Oncolys BioPharma Inc(TSE:4588) pay dividends? If so, how much?
Oncolys BioPharma Inc(TSE:4588) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers